Karachi: GlaxoSmithKline Pakistan Limited has announced the successful credit of its final cash dividend for the fiscal year ending December 31, 2024, marking a significant financial event for its shareholders. The company confirmed that the dividend, calculated at Rs.10.00 per share, equivalent to a 100% dividend, was electronically deposited into the designated bank accounts of its shareholders on May 7, 2025.

This dividend distribution underscores GlaxoSmithKline Pakistan Limited's commitment to delivering value to its investors. The transaction reflects the company's financial performance over the past year and its adherence to shareholder expectations. The crediting of the dividend was executed in compliance with the company's financial calendar and resolutions passed during its annual general meeting.

According to information available from the Pakistan Stock Exchange (PSX), GlaxoSmithKline Pakistan Limited operates within the pharmaceuticals market category. The company has maintained a consistent dividend policy, reinforcing investor confidence through regular and transparent financial communications.

The dividend payment was facilitated through electronic means, ensuring efficiency and security in the transfer of funds to shareholders. This method aligns with GlaxoSmithKline Pakistan Limited's operational standards and the regulatory frameworks governing financial transactions in the region.